Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
St. Jude Children's Research Hospital
University of Southern California
National Cancer Institute (NCI)